These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22531000)

  • 1. The N-terminal region of CXCL11 as structural template for CXCR3 molecular recognition: synthesis, conformational analysis, and binding studies.
    Palladino P; Portella L; Colonna G; Raucci R; Saviano G; Rossi F; Napolitano M; Scala S; Castello G; Costantini S
    Chem Biol Drug Des; 2012 Aug; 80(2):254-65. PubMed ID: 22531000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: putative target for new drug design.
    Trotta T; Costantini S; Colonna G
    Mol Immunol; 2009 Dec; 47(2-3):332-9. PubMed ID: 19800124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational analysis of the human chemokine receptor CXCR3.
    Raucci R; Polo A; Budillon A; Colonna G; Costantini S
    Mol Immunol; 2017 Dec; 92():76-86. PubMed ID: 29054054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
    Xanthou G; Williams TJ; Pease JE
    Eur J Immunol; 2003 Oct; 33(10):2927-36. PubMed ID: 14515277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
    Müller M; Carter S; Hofer MJ; Campbell IL
    Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
    Xanthou G; Duchesnes CE; Williams TJ; Pease JE
    Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
    Costantini S; Raucci R; De Vero T; Castello G; Colonna G
    Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
    Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo.
    Aguilera-Durán G; Romo-Mancillas A
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32992956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
    Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
    J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function.
    Colvin RA; Campanella GS; Sun J; Luster AD
    J Biol Chem; 2004 Jul; 279(29):30219-27. PubMed ID: 15150261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR structure of CXCR3 binding chemokine CXCL11 (ITAC).
    Booth V; Clark-Lewis I; Sykes BD
    Protein Sci; 2004 Aug; 13(8):2022-8. PubMed ID: 15273303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas.
    Lo BK; Yu M; Zloty D; Cowan B; Shapiro J; McElwee KJ
    Am J Pathol; 2010 May; 176(5):2435-46. PubMed ID: 20228225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3.
    Nedjai B; Li H; Stroke IL; Wise EL; Webb ML; Merritt JR; Henderson I; Klon AE; Cole AG; Horuk R; Vaidehi N; Pease JE
    Br J Pharmacol; 2012 Jun; 166(3):912-23. PubMed ID: 21895630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
    Tokunaga R; Zhang W; Naseem M; Puccini A; Berger MD; Soni S; McSkane M; Baba H; Lenz HJ
    Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of overlapping but differential binding sites for the high-affinity CXCR3 antagonists NBI-74330 and VUF11211.
    Scholten DJ; Roumen L; Wijtmans M; Verkade-Vreeker MC; Custers H; Lai M; de Hooge D; Canals M; de Esch IJ; Smit MJ; de Graaf C; Leurs R
    Mol Pharmacol; 2014 Jan; 85(1):116-26. PubMed ID: 24174496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
    Helbig KJ; Ruszkiewicz A; Lanford RE; Berzsenyi MD; Harley HA; McColl SR; Beard MR
    J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Label-free impedance responses of endogenous and synthetic chemokine receptor CXCR3 agonists correlate with Gi-protein pathway activation.
    Watts AO; Scholten DJ; Heitman LH; Vischer HF; Leurs R
    Biochem Biophys Res Commun; 2012 Mar; 419(2):412-8. PubMed ID: 22349504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease.
    Kao J; Kobashigawa J; Fishbein MC; MacLellan WR; Burdick MD; Belperio JA; Strieter RM
    Circulation; 2003 Apr; 107(15):1958-61. PubMed ID: 12695288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.